BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17269616)

  • 1. HER-2 expression and gene amplification in high-grade PIN and prostate cancer.
    Montironi R; Mazzucchelli R
    Arch Ital Urol Androl; 2006 Dec; 78(4):135-9. PubMed ID: 17269616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Lòpez Beltran A; Cheng L; Montorsi F; Scarpelli M
    Eur Urol; 2007 Dec; 52(6):1682-9. PubMed ID: 17368711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
    Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
    Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Int J Immunopathol Pharmacol; 2009; 22(3):755-62. PubMed ID: 19822092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
    Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.
    Morichetti D; Mazzucchelli R; Stramazzotti D; Santinelli A; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
    BJU Int; 2010 Oct; 106(7):1072-80. PubMed ID: 20201837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
    Hall RE; Horsfall DJ; Stahl J; Vivekanandan S; Ricciardelli C; Stapleton AM; Scardino PT; Neufing P; Tilley WD
    Prostate; 2004 Feb; 58(2):103-8. PubMed ID: 14716735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease.
    Shi Y; Brands FH; Chatterjee S; Feng AC; Groshen S; Schewe J; Lieskovsky G; Cote RJ
    J Urol; 2001 Oct; 166(4):1514-9. PubMed ID: 11547123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
    Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
    Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.
    Montironi R; Mazzucchelli R; Santinelli A; Scarpelli M; Beltran AL; Bostwick DG
    Hum Pathol; 2005 Jun; 36(6):646-54. PubMed ID: 16021571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent and zonal distribution of prostatic intraepithelial neoplasia in patients with prostatic carcinoma in Japan: analysis of whole-mounted prostatectomy specimens.
    Shin M; Takayama H; Nonomura N; Wakatsuki A; Okuyama A; Aozasa K
    Prostate; 2000 Feb; 42(2):81-7. PubMed ID: 10617864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens.
    Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K
    Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
    Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
    Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
    BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: existence of HGPIN near prostate cancer.
    Eminaga O; Hinkelammert R; Abbas M; Titze U; Eltze E; Bettendorf O; Semjonow A
    Prostate; 2013 Jul; 73(10):1115-22. PubMed ID: 23532797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.